Auro Laboratories Quarterly Results for Trading Insights
AUROLAB • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹1 Cr
QSept 2025
Auro Laboratories Quarterly Results Key Highlights
- Revenue of ₹10 Cr in Sept 2025 (+233.3% vs Jun 2025, +233.3% vs Sept 2024)
- Net Profit of ₹1 Cr in Sept 2025
- EBITDA of ₹3 Cr in Sept 2025
- Operating Margin of 27.0% in Sept 2025 (+26.0pp vs Jun 2025)
- Earnings Per Share of ₹1.15 in Sept 2025 (+776.5% vs Jun 2025)
Auro Laboratories Quarterly Results Analysis
| Metric | Sept 2025 | Jun 2025 | Sept 2024 | Jun 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 10 | 3 | 3 | 6 | 233.3% | 233.3% |
| Net Profit (₹ Cr) | 1 | 0 | 0 | 1 | - | - |
| EBITDA (₹ Cr) | 3 | 0 | 1 | 2 | - | - |
| EPS (₹) | 1.15 | -0.17 | 0.57 | 1.21 | - | - |
| Operating Margin (%) | 27.0% | 1.0% | 23.0% | 23.0% | - | - |
Auro Laboratories Share Price Trend Around Quarterly Results
Visualize Auro Laboratories's 1-year price movement across quarterly results — ideal for logging trades in Auro Laboratories share price
chart using Tickjournal. All values in ₹.
Related Pages for Auro Laboratories
Additional stock information and data for AUROLAB
Revenue Trend (₹ Cr)
Jun 2024
6
Sept 2024
3
Jun 2025
3
Sept 2025
10
Net Profit Trend (₹ Cr)
Jun 2024
1
Sept 2024
0
Jun 2025
0
Sept 2025
1
Operating Margin Trend (%)
Jun 2024
23.0%
Sept 2024
23.0%
Jun 2025
1.0%
Sept 2025
27.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Auro Laboratories quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹417,052.40 Cr | 1760.7 | 14,875 | 3,125 | +10.8% | - | 21.0% | 135.4 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6600.5 | 2,860 | 689 | +7.1% | - | 24.1% | 254.2 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 4026.4 | 3,219 | 591 | +11.3% | - | 18.4% | 229.6 |
|
Cipla
Sept 2025 |
₹118,572.82 Cr | 1460.6 | 7,716 | 1,353 | +12.0% | - | 17.5% | 87.3 |
|
Dr Reddys Laborator…
Sept 2025 |
₹100,998.62 Cr | 1206.9 | 9,135 | 1,337 | +1.1% | - | 14.6% | 74.6 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores